feed,title,long_url,short_url
Benzinga,Criteo Shares Drop As Q3 Contribution Lags Consensus; Slashes FY22 Outlook,https://benzinga.com/news/earnings/22/10/29459419/criteo-shares-drop-as-q3-contribution-lags-consensus-slashes-fy22-outlook,https://bit.ly/3WcfBhj
Benzinga,MorphoSys Highlights Preliminary Data From Tulmimetostat Study Across Broad Array of Advanced Tumors,https://benzinga.com/general/biotech/22/10/29459467/morphosys-highlights-preliminary-data-from-tulmimetostat-study-across-broad-array-of-advanced-tum,https://bit.ly/3DIq390
Benzinga,4 Pinterest Analysts On Q3 Earnings: Why One Says Results Are 'Stronger Than Expected',https://benzinga.com/analyst-ratings/analyst-color/22/10/29459745/4-pinterest-analysts-on-q3-earnings-why-one-says-results-are-stronger-than-expected,https://bit.ly/3DR0yTf
Benzinga,Why Nuvalent Shares Are Surging 45% Today?,https://benzinga.com/general/biotech/22/10/29459797/why-nuvalent-shares-are-surging-45-today,https://bit.ly/3zpSh5I
